SoftBank-Backed Chinese Cancer Detection Products Developer Gets $66M Fresh Funds

New Horizon Health, a Chinese company that primarily develops cancer detection and screening products, unveiled on Friday that it has secured US$66 million in a series C round of financing led by Hong Kong-based private equity firm VMS Investment Group.

(more…)

SoftBank-Backed Chinese Cancer Detection Products Developer Gets $66M Fresh Funds comes originally from Continue Reading the Entire Article Here >>

This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of

You May Also Like

Ant Financial’s Rural Strategy Focuses On China’s Microfinance Opportunities

Alipay Enters Australia Through Partnership With Paymate

NewQuest Capital Closes Third Fund At $540M